Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
0%
1 month
-3.39%
YTD
14%
1 year
50%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
01 November 24 |
Nasodine COVID-19 Patent Allowed in Mexico
×
Nasodine COVID-19 Patent Allowed in Mexico |
31 October 24 |
Agreement Signed to Market Nasodine to HCPs in Singapore
×
Agreement Signed to Market Nasodine to HCPs in Singapore |
28 October 24 |
Letter to Shareholders & Notice of AGM & Proxy Form
×
Letter to Shareholders & Notice of AGM & Proxy Form |
22 October 24 |
September 2024 Quarterly Activity Report & Appendix 4C
×
September 2024 Quarterly Activity Report & Appendix 4C |
16 October 24 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
16 October 24 |
Cleansing Notice
×
Cleansing Notice |
10 October 24 |
Completion of Share Purchase Plan
×
Completion of Share Purchase Plan |
10 October 24 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
10 October 24 |
Proposed issue of securities - FRE
×
Proposed issue of securities - FRE |
10 October 24 |
Change of Director's Interest Notice - Peter Molloy
×
Change of Director's Interest Notice - Peter Molloy |
10 October 24 |
Change of Director's Interest Notice - Stephen Goodall
×
Change of Director's Interest Notice - Stephen Goodall |
01 October 24 |
Final Director's Interest Notice - Richard Treagus
×
Final Director's Interest Notice - Richard Treagus |
01 October 24 |
Firebrick Investor Update Webinar Recording
×
Firebrick Investor Update Webinar Recording |
30 September 24 |
Notice of AGM and Closing Date for Director Nominations
×
Notice of AGM and Closing Date for Director Nominations |
25 September 24 |
Firebrick Investor Update
×
Firebrick Investor Update |
23 September 24 |
Firebrick receives $0.9 million R&D Tax Incentive
×
Firebrick receives $0.9 million R&D Tax Incentive |
17 September 24 |
Cleansing Notice Pursuant to Share Purchase Plan
×
Cleansing Notice Pursuant to Share Purchase Plan |
17 September 24 |
Share Purchase Plan Open
×
Share Purchase Plan Open |
12 September 24 |
Share Purchase Plan
×
Share Purchase Plan |
12 September 24 |
Proposed issue of securities - FRE
×
Proposed issue of securities - FRE |
12 September 24 |
Resignation of Director Dr Richard Treagus
×
Resignation of Director Dr Richard Treagus |
10 September 24 |
Notification regarding unquoted securities - FRE
×
Notification regarding unquoted securities - FRE |
09 September 24 |
Nasodine European Marketing Application Filed and Validated
×
Nasodine European Marketing Application Filed and Validated |
09 September 24 |
FRE Consultant to Drive Pharmacy Distribution in Singapore
×
FRE Consultant to Drive Pharmacy Distribution in Singapore |
09 September 24 |
Proposed issue of securities - FRE
×
Proposed issue of securities - FRE |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.